Increasing use of artemisinin-based combination therapy for treatment of malaria infection in Nigerian hospitals

  • Nneka U. Igboeli
  • Chinwe V. Ukwe
  • Obinna I. Ekwunife
Keywords: Guideline Adherence, Antimalarials, Nigeria

Abstract

Objectives: This study aimed at describing the pattern of outpatient antimalarial drug prescribing in a secondary and a tertiary hospital, and to assess adherence to the National Antimalarial Treatment Guideline (ATG).

Methods: An audit of antimalarial prescription files from the two health facilities for a period of six months in 2008 was conducted. Semi structured questionnaires were used to collect information from the doctors and pharmacists on their awareness and knowledge of the National Antimalarial Treatment Guideline.

Results: Artemisinin-based combination therapies (ACTs) were the most prescribed antimalarials. Overall, 81.4% of the total prescriptions contained ACTs, out of which 56.8% were artemether-lumefantrine. However, adherence to the drugs indicated by national guideline within the DU90% was 38.5% for the tertiary and 66.7 % for the secondary hospital. The standard practice of prescribing with generic name was still not adhered to as evidenced in the understudied hospitals. The percentage of health care providers that were aware of the ATG was 88.2% for doctors and 85.1% for pharmacists. However, 13.3% and 52.2% of doctors and pharmacists respectively could not properly list the drugs specified in the guideline. Amodiaquine was the most commonly preferred option for managing children aged 0 – 3 months with malaria infection against the indicated oral quinine.

Conclusion: This study showed an increased use of artemisinin-based combination therapy for the treatment of uncomplicated malaria compared previous reports in Nigeria. This study also highlights the need for periodic in-service quality assurance among health professionals with monitoring of adherence to and assessment of knowledge of clinical guidelines to ensure the practice of evidence based medicine.

Downloads

Download data is not yet available.

References

1. Federal Ministry of Health: The National Health Policy of Nigeria. Federal Ministry of Health, Abuja Nigeria. 1992.

2. Band JR. Resurgent malaria at the millennium: control strategies in crisis. Drugs. 2000;59:719-743.

3. Guerin PJ, Olliaro P, Nosten F, Druilhe P, Laxminarayan R, Blinka F, Kilama WL, Ford N, White J. Malaria: current status of control, diagnosis, treatment and a proposed agenda for research and development. Lancet Infect Dis. 2002;2:564-573.

4. Baird JK. Effectiveness of Antimalarial Drugs. N Engl J Med. 2005;352:1565-1577.

5. Biswas NR, Biswas RS, Pal PS, Jain SK, Malhotra SP, Gupta A, Pal SN. Patterns of prescriptions and drug use in two tertiary hospitals in Delhi. Ind J Physiol Pharmacol. 2000;44:109-112.

6. Ukwe CV, Ekwunife OI. Drug utilization study of antimalarials for the treatment of hospitalized children under five in south-eastern Nigeria. Pharmacoepdemiol Drug Saf. 2008;17:1183-1188.

7. Mokuolu OA, Okoro EO, Ayetoro SO, Adewara AA. Effect of artemisinin-based treatment policy on consumption pattern of antimalarials. Am J Trop Med Hyg. 2007;76(1):7-11.

8. Oshikoya KA. Antimalarial Prescriptions for Children Presenting with Uncomplicated Malaria to a Teaching Hospital in Nigeria after the Change of National Guidelines for Malaria Treatment. World J Med Sci. 2007;2(1):49-53.

9. How to investigate drug use in health facilities: selected drug indicators. Action Programme on Essential Drugs (WHO/DAP/ (93.11) Geneva, World Health Organization, 1993.

10. Meremikwu M, Okomo U, Nwachukwu C, Oyo-Ita A, Eke-Njoku J, okebe J, Oyo-Ita E, Garner P. Antimalarial drug prescribing practice in private and public health facilities in south-east Nigeria: a descriptive study. Malar J. 2007;6:55.

11. Dodo ANO, Fogg C, Asiimwe, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy. Malar J. 2009;8:2.

12. Munier A, Diallo A, Cot M, Ndiaye O, Arduin P, Chippaux J. Antimalarial prescriptions in three health care facilities after the emergence of chloroquine resistance in Niakhar, Senegal (1992-2004). Malar J. 2009;8:83.

13. Baume C, Helitzer-Allen D, Achur P. Patterns of care for childhood malaria in Zambia. Soc Sci Med. 2005;51:1491-1503.

14. Popa C. DU90 for the assessment of drug prescribing in a primary care. MPH 2005:18.

15. Bornstein BH, Emier AC. Rationality in medical decision-making: a review of the literature on doctors’ decision- making biases. J Eval Clin Pract. 2001;7:97-107.

16. Federal Ministry of Health. National Antimalarial Treatment Policy. Federal Ministry of Health, Nigeria. 2005.

17. Tracy JW, Webster LT. Malaria In: Hardman JG, Limbird LE, Gilman AG (Ed). Goodman and Gilman’s - The pharmacological basis of therapeutics. 10 edition. McGraw-Hill Companies, Inc. Unites States of America. 2001. Pp1075(1069-1095).

18. Ibrahim MTO. Physicians’ prescribing behaviour in two tertiary health care facilities in north western Nigeria. Analysis of 518 prescriptions. Sahel Med J. 2004;7:115-118.

19. Akande TM, Ologe MO. Prescription pattern at a secondary health care facility in Ilorin, Nigeria. Ann Afr Med. 2007;6(4):186-189.

20. Lamichane DC, Giri BR, Pathak OK, Panta OB, Shankar PR. Morbidity profile and prescribing pattern among outpatient in a tertiary teaching hospital in western Nepal. McGill J Med. 2006;9(2):126-133.

21. Helper CD, Strand LM. Opportunities and Responsiblities in Pharmaceutical Care. Am J Hosp Pharm. 1990;43:533-534.

22. Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Åberg H, Sjӧqvist F. drug utilization 90% - a Simple Method for assessing the quality of drug prescribing. Eur J Clin Pharmacol. 1998;54:113-118.
Published
2010-12-20
How to Cite
1.
Igboeli NU, Ukwe CV, Ekwunife OI. Increasing use of artemisinin-based combination therapy for treatment of malaria infection in Nigerian hospitals. Pharm Pract (Granada) [Internet]. 2010Dec.20 [cited 2019Jul.23];8(4):243-9. Available from: https://pharmacypractice.org/journal/index.php/pp/article/view/97
Section
Original Research